Camille Bigenwald

4.0k total citations
22 papers, 179 citations indexed

About

Camille Bigenwald is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Camille Bigenwald has authored 22 papers receiving a total of 179 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Camille Bigenwald's work include Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Camille Bigenwald is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), CAR-T cell therapy research (5 papers) and Immune Cell Function and Interaction (5 papers). Camille Bigenwald collaborates with scholars based in France, United States and Switzerland. Camille Bigenwald's co-authors include Kenneth L. McClain, Miriam Mérad, Carl E. Allen, Jennifer Picarsic, Karina Braga Ribeiro, Matthew Collin, Julien Haroche, Rebecca Marsh, Vincent Ribrag and Olive S. Eckstein and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Camille Bigenwald

17 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Bigenwald France 7 73 60 51 41 37 22 179
Krisztián Kállay Hungary 9 30 0.4× 53 0.9× 65 1.3× 19 0.5× 25 0.7× 27 196
Luděk Pour Czechia 8 53 0.7× 51 0.8× 69 1.4× 18 0.4× 16 0.4× 88 206
Masaru Karakawa Japan 9 46 0.6× 229 3.8× 35 0.7× 12 0.3× 31 0.8× 14 287
Bernhard Fahrner Austria 5 136 1.9× 23 0.4× 17 0.3× 70 1.7× 32 0.9× 7 236
Bettina Bannert Switzerland 7 24 0.3× 35 0.6× 32 0.6× 12 0.3× 22 0.6× 13 158
Emine Figen Tarhan Türkiye 8 30 0.4× 44 0.7× 16 0.3× 7 0.2× 30 0.8× 25 170
Maiko Yoshimura Japan 9 17 0.2× 76 1.3× 14 0.3× 22 0.5× 15 0.4× 19 213
Robert Greiner United States 5 10 0.1× 92 1.5× 34 0.7× 10 0.2× 19 0.5× 22 218
Naoki Tode Japan 9 40 0.5× 16 0.3× 23 0.5× 24 0.6× 10 0.3× 15 220
Giuseppe Cillis Italy 8 128 1.8× 40 0.7× 27 0.5× 6 0.1× 21 0.6× 10 378

Countries citing papers authored by Camille Bigenwald

Since Specialization
Citations

This map shows the geographic impact of Camille Bigenwald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Bigenwald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Bigenwald more than expected).

Fields of papers citing papers by Camille Bigenwald

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Bigenwald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Bigenwald. The network helps show where Camille Bigenwald may publish in the future.

Co-authorship network of co-authors of Camille Bigenwald

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Bigenwald. A scholar is included among the top collaborators of Camille Bigenwald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Bigenwald. Camille Bigenwald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergé, Véronique, Arnaud Pagès, Vincent Ribrag, et al.. (2025). CAR T cell–mediated bone marrow inflammation causes hematotoxicity and favors clonal hematopoiesis. Science Translational Medicine. 17(817). eadu9790–eadu9790.
2.
Bigenwald, Camille, et al.. (2025). Should adolescents and young adults with Hodgkin lymphoma be treated as children or adults?. British Journal of Haematology. 206(3). 907–918.
3.
4.
Alsuliman, Tamim, Jacques Olivier Bay, Yves Béguin, et al.. (2024). Toxicités hématologiques après CAR-T cells, recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer. 112(1). S103–S110. 1 indexed citations
5.
Pagès, Arnaud, Véronique Vergé, Cyril Quivoron, et al.. (2024). 803MO CAR T cells reside in the bone marrow and inhibits healthy hematopoiesis. Annals of Oncology. 35. S597–S598.
6.
Saleh, Khalil, Florence Pasquier, Camille Bigenwald, et al.. (2023). CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Medicine. 12(21). 6883–6883. 7 indexed citations
7.
Assaad, Souad, Jean‐Yves Blay, Pierre-Étienne Heudel, et al.. (2023). 846P Artificial intelligence-driven identification of onco-hematology patients who may develop severe COVID-19. Annals of Oncology. 34. S551–S551. 1 indexed citations
8.
Willekens, Christophe, Claude Chahine, Camille Bigenwald, et al.. (2023). When monoclonal gammopathy‐associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes. SHILAP Revista de lepidopterología. 4(3). 823–826. 2 indexed citations
9.
Saleh, Khalil, David Ghez, Camille Bigenwald, et al.. (2023). Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation. Immunotherapy. 15(6). 401–407. 2 indexed citations
10.
Bigenwald, Camille, Yacine Haddad, Cassandra Thélémaque, et al.. (2023). RBD- specific Th1 responses are associated with vaccine-induced protection against SARS-CoV-2 infection in patients with hematological malignancies. OncoImmunology. 12(1). 2163785–2163785. 5 indexed citations
11.
Bigenwald, Camille, et al.. (2022). Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?. Blood. 140(Supplement 1). 1749–1750. 1 indexed citations
12.
Michot, Jean‐Marie, Maxime Annereau, Alina Danu, et al.. (2021). Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma. Cancer Drug Resistance. 4(3). 710–718. 3 indexed citations
13.
McClain, Kenneth L., Camille Bigenwald, Matthew Collin, et al.. (2021). Histiocytic disorders. Nature Reviews Disease Primers. 7(1). 73–73. 68 indexed citations
14.
Michot, Jean‐Marie, Séverine Mouraud, Julien Adam, et al.. (2021). CD8+ T Lymphocytes Immune Depletion and LAG-3 Overexpression in Hodgkin Lymphoma Tumor Microenvironment Exposed to Anti-PD-1 Immunotherapy. Cancers. 13(21). 5487–5487. 9 indexed citations
15.
Burke, Thomas M., Harshal Abhyankar, Brooks Scull, et al.. (2020). Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH. Blood. 137(13). 1777–1791. 28 indexed citations
16.
Abhyankar, Harshal, Thomas M. Burke, Brooks Scull, et al.. (2019). Blocking MAPK Activation and Immune Checkpoints Reverse Immune Dysfunction and Reduce Disease in a Mouse Model of LCH. Blood. 134(Supplement_1). 3602–3602. 1 indexed citations
17.
Bigenwald, Camille, Amir Horowitz, Shyamala Navada, et al.. (2019). Cross Talk between the Immune Compartment and the Tumor Cells in Myelodysplastic Syndromes (MDS). Blood. 134(Supplement_1). 2986–2986. 1 indexed citations
18.
Bigenwald, Camille, L. Fardet, Paul Coppo, et al.. (2018). A comprehensive analysis of Lymphoma‐associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. British Journal of Haematology. 183(1). 68–75. 25 indexed citations
19.
Bigenwald, Camille, Jacques‐Emmanuel Galimard, L. Quéro, et al.. (2017). Hodgkin lymphoma in adolescent and young adults: insights from an adult tertiary single-center cohort of 349 patients. Oncotarget. 8(45). 80073–80082. 11 indexed citations
20.
Deval, Bruno, Pascal Rousset, Camille Bigenwald, Francisco F. Nogales, & Jérôme Alexandre. (2014). Treatment of Ovarian Anaplastic Ependymoma by an Aromatase Inhibitor. Obstetrics and Gynecology. 123(2). 488–491. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Krisztián Kállay Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Masaru Karakawa Breakdown of academic impact, for papers by Bernhard Fahrner Breakdown of academic impact, for papers by Bettina Bannert Breakdown of academic impact, for papers by Emine Figen Tarhan Breakdown of academic impact, for papers by Maiko Yoshimura Breakdown of academic impact, for papers by Robert Greiner Breakdown of academic impact, for papers by Naoki Tode Breakdown of academic impact, for papers by Giuseppe Cillis
Rankless by CCL
2026